HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kai Zhang Selected Research

ziyuglycoside I

1/2018Triggering p53 activation is essential in ziyuglycoside I-induced human retinoblastoma WERI-Rb-1 cell apoptosis.
11/2016Ziyuglycoside I Inhibits the Proliferation of MDA-MB-231 Breast Carcinoma Cells through Inducing p53-Mediated G2/M Cell Cycle Arrest and Intrinsic/Extrinsic Apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kai Zhang Research Topics

Disease

320Neoplasms (Cancer)
08/2022 - 06/2003
66Inflammation (Inflammations)
07/2022 - 06/2006
63Breast Neoplasms (Breast Cancer)
01/2022 - 01/2013
54Neoplasm Metastasis (Metastasis)
06/2022 - 09/2012
45Infections
10/2022 - 04/2003
36Carcinogenesis
03/2022 - 02/2014
35Lung Neoplasms (Lung Cancer)
07/2021 - 01/2012
30Fibrosis (Cirrhosis)
09/2022 - 11/2009
29Hypoxia (Hypoxemia)
09/2022 - 09/2006
29Hepatocellular Carcinoma (Hepatoma)
01/2022 - 06/2003
27Adenocarcinoma of Lung
05/2022 - 08/2011
23Wounds and Injuries (Trauma)
07/2022 - 07/2005
22Sepsis (Septicemia)
10/2022 - 11/2006
22COVID-19
07/2022 - 01/2020
22Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2012
20Carcinoma (Carcinomatosis)
01/2022 - 07/2004
19Reperfusion Injury
03/2022 - 12/2003
19Ischemia
03/2022 - 12/2003
17Schizophrenia (Dementia Praecox)
03/2022 - 01/2014
17Glioma (Gliomas)
02/2022 - 08/2007
15Colorectal Neoplasms (Colorectal Cancer)
06/2022 - 01/2014
15Stroke (Strokes)
06/2022 - 07/2003
15Prostatic Neoplasms (Prostate Cancer)
01/2022 - 06/2005
15Pain (Aches)
10/2021 - 03/2011
14Hypertension (High Blood Pressure)
09/2022 - 09/2006
14Stomach Neoplasms (Stomach Cancer)
01/2022 - 01/2013
14Body Weight (Weight, Body)
03/2021 - 11/2011
13Lymphatic Metastasis
01/2022 - 04/2013
13Colonic Neoplasms (Colon Cancer)
10/2021 - 04/2003
13Hemorrhage
01/2021 - 08/2005
12Mitochondrial Diseases (Mitochondrial Disease)
01/2022 - 03/2014
12Parkinson Disease (Parkinson's Disease)
11/2021 - 04/2011
12Atherosclerosis
07/2020 - 09/2010
11Cognitive Dysfunction
01/2022 - 03/2010
11Infarction (Infarctions)
10/2021 - 03/2006
11Heart Failure
10/2021 - 07/2014
11Chordoma
01/2021 - 04/2014
10Alzheimer Disease (Alzheimer's Disease)
07/2022 - 10/2010
10Epilepsy (Aura)
01/2022 - 08/2013
10Type 2 Diabetes Mellitus (MODY)
11/2021 - 02/2003
10Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 05/2007
9Esophageal Squamous Cell Carcinoma
01/2022 - 02/2014
9Hypertrophy
01/2022 - 11/2009
9Melanoma (Melanoma, Malignant)
03/2021 - 08/2012
9Brain Injuries (Brain Injury)
12/2020 - 04/2012
9Uterine Cervical Neoplasms (Cancer of the Cervix)
09/2020 - 01/2011
8Temporal Lobe Epilepsy
06/2022 - 06/2011
8Seizures (Absence Seizure)
01/2022 - 09/2012
8Atherosclerotic Plaque (Atheroma)
01/2022 - 05/2012
8Insulin Resistance
10/2021 - 01/2015
8Obesity
06/2021 - 04/2014
8Myocardial Ischemia (Ischemic Heart Diseases)
07/2020 - 05/2009
7Atrial Remodeling
09/2022 - 08/2018

Drug/Important Bio-Agent (IBA)

113Proteins (Proteins, Gene)FDA Link
08/2022 - 11/2004
66Biomarkers (Surrogate Marker)IBA
03/2022 - 01/2006
66MicroRNAs (MicroRNA)IBA
01/2022 - 02/2014
44Pharmaceutical PreparationsIBA
07/2022 - 04/2002
39Messenger RNA (mRNA)IBA
01/2022 - 06/2003
32Biological ProductsIBA
07/2022 - 06/2006
31CytokinesIBA
08/2022 - 12/2003
29Long Noncoding RNAIBA
05/2022 - 01/2015
25LeptinIBA
01/2021 - 12/2003
20RNA (Ribonucleic Acid)IBA
07/2022 - 01/2011
19Glucose (Dextrose)FDA LinkGeneric
01/2022 - 10/2012
18CollagenIBA
07/2022 - 09/2010
17EnzymesIBA
01/2022 - 03/2006
16Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 11/2009
14Triglycerides (Triacylglycerol)IBA
09/2022 - 01/2004
14Therapeutic UsesIBA
06/2022 - 03/2002
14AntigensIBA
01/2022 - 05/2013
14Transcription Factors (Transcription Factor)IBA
05/2021 - 08/2011
13Small Interfering RNA (siRNA)IBA
03/2022 - 08/2011
13DNA (Deoxyribonucleic Acid)IBA
01/2022 - 06/2003
11Anti-Bacterial Agents (Antibiotics)IBA
10/2022 - 06/2005
11LipidsIBA
09/2022 - 05/2012
11LigandsIBA
01/2022 - 01/2013
10CateninsIBA
07/2022 - 01/2014
10Interleukin-6 (Interleukin 6)IBA
06/2022 - 10/2014
10salicylhydroxamic acid (SHAM)IBA
06/2022 - 02/2005
10Blood Glucose (Blood Sugar)IBA
10/2021 - 10/2012
10Indicators and Reagents (Reagents)IBA
10/2021 - 01/2011
10Neuroprotective AgentsIBA
01/2021 - 04/2011
9Particulate MatterIBA
09/2022 - 08/2014
9Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
06/2022 - 01/2016
9Docetaxel (Taxotere)FDA Link
01/2022 - 08/2014
9oxidized low density lipoproteinIBA
06/2021 - 05/2012
8HMGB1 Protein (HMG1)IBA
08/2022 - 12/2012
8ErbB Receptors (EGF Receptor)IBA
01/2021 - 01/2011
81-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2021 - 05/2005
8C-Reactive ProteinIBA
05/2020 - 09/2005
7HydrogelsIBA
07/2022 - 08/2017

Therapy/Procedure

131Therapeutics
07/2022 - 04/2002
41Drug Therapy (Chemotherapy)
06/2022 - 05/2005
25Immunotherapy
03/2022 - 02/2015
20Deep Brain Stimulation
05/2021 - 05/2006
16Length of Stay
01/2022 - 04/2014
14Radiotherapy
01/2022 - 03/2008
10Punctures
10/2022 - 11/2006
9Chinese Traditional Medicine (Traditional Chinese Medicine)
10/2021 - 12/2016
8Transplantation
10/2022 - 01/2016